African Americans and AIDS Conference, Feb. 19-20, Washington, D.C.: Fauci, Gayle, Primm, Other Speakers.
This conference comes shortly after news of disastrous rates of HIV infection among gay African Americans and other minorities. An epidemiological study in New York City found HIV infection rate now more than 10 times as high among African Americans than among whites (33% vs. 2%) in gay men age 23-29. The researchers found no behavioral risk factor which could explain the difference. The study, by L. Torian and others, will be presented at the Retroviruses conference in early February; a report appeared February 24 in New York Newsday.
Program of February 19-20 Conference
The current program includes:
* Sandra L. Thurman: Africa Update
* Special guest speaker: topic to be announced
* Eric P. Goosby, M.D.: A Bridge to Common Experiences
* Elaine M. Daniels, M.D., Ph.D.: The Epidemiology of HIV in the United States
* John G. Bartlett, M.D., and Eric P. Goosby, M.D.: The Kaiser Family Foundation/U.S. Department of Health and Human Services Treatment Guidelines [new guidelines, to be released in early February].
* Valerie Stone, M.D.: The Clinical Management of the HIV/AIDS Patient
* Robert C. Gallo, M.D.: New Approaches to Therapy
* Working lunch: panel, with Phill Wilson moderator
* Anthony S. Fauci, M.D.: Drug Holidays, Structured Treatment Interruptions, and Structured Intermittent Therapy
* Jonathan Zenilman, M.D. and Celia J. Maxwell, M.D. F.A.C.P.: Men, Women, and Sexually Transmitted Diseases
* David L. Thomas, M.D., J.D.: Hepatitis and HIV
* Henry "Skip" Francis, M.D.: Legal and Illegal Drug Use
* Cornelius Baker: topic to be announced
* Robert Fullilove III, Ph.D.: Does Culture Affect Adherence?
* Helene Gayle, M.D., Ph.D.: The Life Initiative/Epidemiology -- A Focus on Africa
* Beny J. Primm, M.D.: Special remarks
* Jean R. Anderson, M.D., and Lynne Mofenson, M.D.: Pregnancy, Birth, and HIV Transmission
* Speaker to be announced: Women's Issues
* Deborah Parham, M.D.: Ryan White and the Challenge of Africa
* Working lunch: panel, focus on women with female partners
* Glenn J. Triesman, M.D., Ph.D.: Psychiatric Issues
* William H Ruby, M.D.: Incarcerated Populations
* Phill Wilson: topic to be announced
* Stephen B. Thomas, Ph.D.: Closing Remarks
Registration: There is no fee to register, and the registration desk will remain open through the conference. It is best to register early, by contacting Stacey Everett at Firehouse Event Planning, phone 609-936-1966, fax 609-936-0479.
Continuing education credit: 16 hours Category One, no fee.
This program is funded through unrestricted educational grants provided by:
* Bristol-Myers Squibb Company
* The Body.Com
* The U.S Health Resources Services Administration HIV/AIDS Bureau
* Serono Laboratories, Inc.
* OraSure Technologies, Inc.
At a time of growing problems around the pharmaceutical industry and its relationship to individual and public health goals, the program stands out as a clear success. For the first two years it was funded entirely by Bristol-Myers Squibb; this year funding is from multiple sources.
Yes, the conference serves a marketing purpose, since more attention on this issue will probably result in more African Americans with HIV receiving medical care -- and some of them will use the sponsors' high-profit antiretrovirals. But here the corporate purpose is consistent with the public goal of getting people with HIV into medical care, so that they and their doctors can make informed decisions about what treatment, if any, to begin. In this case, public and commercial goals coincide.
|Printer friendly Cite/link Email Feedback|
|Publication:||AIDS Treatment News|
|Date:||Jan 26, 2001|
|Previous Article:||First HIV Vaccine for Africa Begins Trials.|
|Next Article:||United Nations AIDS Session: Email Input Sought.|